About this item:
648 Views | 384 Downloads
Author Notes:
Dr. Vasilis Babaliaros, Emory University, Hospital F606, 1364 Clifton Road, Atlanta, Georgia 30322. vbabali@emory.edu.
The authors are grateful to Dr. Melissa Fusari for her clinical guidance.
Dr. Sanon has served as a proctor and consultant or speaker for Edwards Lifesciences, Abbott Vascular, St. Jude Medical, and Baylis Medical; and has equity interest in Edwards Lifesciences and in Boston Scientific.
Dr. Leshnower is on the Speaker Bureau for Medtronic.
Dr. Lerakis has served as a consultant for Abbott Vascular; and his employer has research contracts for multicenter investigation of transcatheter aortic and mitral devices from Edwards Lifesciences, Abbott Vascular, Medtronic, St. Jude Medical, and Boston Scientific.
Dr. Greenbaum has served as a proctor for Edwards Lifesciences and St. Jude Medical.
Dr. Babaliaros has served as a consultant and investigator for Edwards Lifesciences and for Abbott Vascular; and his employer has research contracts for multicenter investigation of transcatheter aortic and mitral devices from Edwards Lifesciences, Abbott Vascular, Medtronic, St. Jude Medical, and Boston Scientific.
All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Subject:
Research Funding:
The work was supported by the Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health Grant No. Z01-HL006040.
Keywords:
- Science & Technology
- Life Sciences & Biomedicine
- Cardiac & Cardiovascular Systems
- Cardiovascular System & Cardiology
- Alfieri stitch
- catheter electrosurgery
- transcatheter mitral valve replacement
- OBSTRUCTION
- LEAFLET
Transcatheter Mitral Valve Replacement After Transcatheter Electrosurgical Laceration of Alfieri STItCh (ELASTIC) First-in-Human Report
Abstract:
Copyright information:
© 2018 Published by Elsevier on behalf of the American College of Cardiology Foundation
